New Opportunities Audubon

New Opportunities Audubon is an addiction-treatment facility located in Audubon, IA. The facility's programming is outpatient (Outpatient), not residential. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at New Opportunities Audubon

On care levels specifically: New Opportunities Audubon is an outpatient-focused program (Outpatient) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. What that means in practice is that matching New Opportunities Audubon to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

New Opportunities Audubon accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Before you call

Before admission to New Opportunities Audubon, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether New Opportunities Audubon offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.